Aurobindo arm Lannett’s facility in U.S. gets 4 U.S. FDA observations
The U.S. Food and Drug Administration (FDA) has issued four observations to Lannett Company LLC, a U.S. subsidiary of Aurobindo Pharma, following a routine inspection of its manufacturing facility in Seymour, Indiana. The inspection was conducted from August 17 to 21 and concluded with four observations, which the company described as procedural in nature. Aurobindo…
Read More “Aurobindo arm Lannett’s facility in U.S. gets 4 U.S. FDA observations” »